Using taurolidine to attenuate the surgically-induced endotoxaemia and the subsequent inflammatory response in patients with primary non-metastatic colon cancer.
Phase of Trial: Phase III
Latest Information Update: 17 Aug 2018
At a glance
- Drugs Taurolidine (Primary)
- Indications Bacterial infections; Endotoxinaemia
- Focus Pharmacodynamics
- Sponsors Geistlich
- 27 Nov 2007 New trial record.